title: Prediction and prevention of the first psychotic episode: new directions and opportunities.
abstract: In the last few decades, substantial research has focused on the possibility of early detection and prevention of the first psychotic episode in young individuals at risk of developing this mental disturbance; however, unresolved clinical and ethical issues still call for further investigations. New perspectives and opportunities may come from the identification of selective psychopathological and instrumental markers linking the appearance of subtle psychotic symptoms with the clinical outcome of specific mental pathologies. Furthermore, empirically derived algorithms and risk staging models should facilitate the identification of targeted prevention therapies, possibly improving the efficacy of well-tolerated therapeutic approaches, such as psychological interventions and natural compound supplementations. To date, the collected evidence on the efficacy and tolerability of pharmacological prevention therapies raises more doubts than hopes. A very early detection of risk and appropriate symptomatic pattern classifications may provide a chance to better match prevention strategies with the development of psychosis.
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Piras
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Gianluca
authors.initials: G
authors.lastname: Casu
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Maria Antonietta
authors.initials: MA
authors.lastname: Casu
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Orrù
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Ruiu
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Pilleri
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Manca
authors.affiliation: National Research Council, institute of Translational Pharmacology, Strategic Operating Unit of Cagliari, Cagliari, Italy.
authors.forename: Giorgio
authors.initials: G
authors.lastname: Marchese
keywords: basic symptoms; psychosis; risk; schizophrenia; therapy
references.citation: Schizophr Bull. 2010 Jan;36(1):182-91
references.pmid: 18579555
references.citation: Psychiatry Res. 2012 Jan 30;201(1):34-9
references.pmid: 22281200
references.citation: Schizophr Res. 2011 Jun;129(1):20-8
references.pmid: 21507614
references.citation: Psychoneuroendocrinology. 2012 Oct;37(10):1600-13
references.pmid: 22663896
references.citation: J Neurosci Res. 2012 Jan;90(1):288-306
references.pmid: 21932359
references.citation: Mol Psychiatry. 2014 Mar;19(3):317-24
references.pmid: 23478748
references.citation: Am J Psychiatry. 2003 Oct;160(10):1790-4
references.pmid: 14514492
references.citation: Schizophr Res. 2009 Nov;115(1):50-7
references.pmid: 19709859
references.citation: BMJ. 2013 Jan 18;346:f185
references.pmid: 23335473
references.citation: Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S162-7
references.pmid: 14677074
references.citation: Arch Psychiatr Nervenkr (1970). 1982;231(6):519-26
references.pmid: 7138278
references.citation: Front Cell Neurosci. 2013 May 15;7:60
references.pmid: 23720610
references.citation: Schizophr Bull. 2003;29(4):703-15
references.pmid: 14989408
references.citation: Psychopharmacology (Berl). 2010 Dec;212(4):635-42
references.pmid: 20734030
references.citation: Eur Psychiatry. 2005 Jan;20(1):1-6
references.pmid: 15642437
references.citation: Schizophr Res. 2013 May;146(1-3):69-78
references.pmid: 23473813
references.citation: Arch Gen Psychiatry. 2001 Feb;58(2):158-64
references.pmid: 11177117
references.citation: Can J Psychiatry. 2013 Jul;58(7):402-8
references.pmid: 23870722
references.citation: Schizophr Res. 2011 Oct;132(1):8-17
references.pmid: 21784618
references.citation: Eur Neuropsychopharmacol. 2013 Aug;23(8):931-40
references.pmid: 23089076
references.citation: Br J Psychiatry. 2012 Jan;200(1):22-9
references.pmid: 22075649
references.citation: Can J Psychiatry. 2010 Aug;55(8):486-97
references.pmid: 20723276
references.citation: JAMA Psychiatry. 2013 Aug;70(8):793-802
references.pmid: 23739772
references.citation: Early Interv Psychiatry. 2012 May;6(2):201-6
references.pmid: 22510335
references.citation: Schizophr Res. 2006 Jul;85(1-3):124-31
references.pmid: 16650735
references.citation: Nutr Res Rev. 1999 Dec;12(2):231-53
references.pmid: 19087453
references.citation: Br J Psychiatry Suppl. 2007 Dec;51:s96-101
references.pmid: 18055946
references.citation: Schizophr Res. 2013 Aug;148(1-3):163-7
references.pmid: 23778032
references.citation: Curr Pharm Des. 2012;18(12):1568-79
references.pmid: 22280434
references.citation: CNS Spectr. 2007 Mar;12(3 Suppl 4):1-13; quiz 14
references.pmid: 17329984
references.citation: Schizophr Res. 2004 Apr 1;67(2-3):131-42
references.pmid: 14984872
references.citation: Schizophr Res. 2008 Oct;105(1-3):10-7
references.pmid: 18765167
references.citation: Adm Policy Ment Health. 2007 Sep;34(5):435-42
references.pmid: 17653845
references.citation: J Clin Psychiatry. 2007 Apr;68(4):546-57
references.pmid: 17474810
references.citation: Curr Pharm Des. 2012;18(4):570-5
references.pmid: 22239590
references.citation: Schizophr Bull. 2012 Nov;38(6):1130-4
references.pmid: 23144056
references.citation: Acta Psychiatr Scand. 2003 Aug;108(2):126-33
references.pmid: 12823169
references.citation: Schizophr Res. 2003 Mar 1;60(1):21-32
references.pmid: 12505135
references.citation: Schizophr Bull. 2012 Nov;38(6):1180-8
references.pmid: 22941746
references.citation: Arch Gen Psychiatry. 2010 Feb;67(2):146-54
references.pmid: 20124114
references.citation: Br J Psychiatry. 2011 Nov;199(5):361-6
references.pmid: 22045944
references.citation: Schizophr Res. 2013 May;146(1-3):79-86
references.pmid: 23510595
references.citation: Schizophr Res. 2012 Jul;138(2-3):192-7
references.pmid: 22464922
references.citation: Clin Neuropharmacol. 2013 May-Jun;36(3):98-9
references.pmid: 23673914
references.citation: Schizophr Bull. 2007 May;33(3):682-7
references.pmid: 16973786
references.citation: Schizophr Bull. 2009 Sep;35(5):894-908
references.pmid: 19386578
references.citation: J Child Adolesc Psychopharmacol. 2008 Oct;18(5):475-90
references.pmid: 18928412
references.citation: Arch Gen Psychiatry. 2010 Mar;67(3):241-51
references.pmid: 20194824
references.citation: Eur Arch Psychiatry Clin Neurosci. 1996;246(3):147-54
references.pmid: 8739400
references.citation: Early Interv Psychiatry. 2007 Feb;1(1):71-8
references.pmid: 21352110
references.citation: Lancet. 2007 Nov 24;370(9601):1746-8
references.pmid: 18037073
references.citation: Psychiatry Res. 2012 Apr 30;196(2-3):220-4
references.pmid: 22445704
references.citation: Schizophr Res. 2006 Jan 1;81(1):83-90
references.pmid: 16297599
references.citation: Schizophr Bull. 2007 May;33(3):673-81
references.pmid: 17404389
references.citation: Schizophr Bull. 2011 Sep;37 Suppl 2:S111-21
references.pmid: 21860040
references.citation: Br J Psychiatry Suppl. 2007 Dec;51:s31-7
references.pmid: 18055935
references.citation: Neuropsychopharmacology. 2012 Jan;37(1):309-10
references.pmid: 22157875
references.citation: J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35
references.pmid: 22166172
references.citation: Neuropsychopharmacology. 2011 Aug;36(9):1781-91
references.pmid: 21508933
references.citation: Am J Psychiatry. 2006 May;163(5):790-9
references.pmid: 16648318
references.citation: Schizophr Res. 2011 Oct;132(1):54-61
references.pmid: 21813266
references.citation: JAMA Psychiatry. 2013 Jan;70(1):107-20
references.pmid: 23165428
references.citation: Curr Pharm Des. 2012;18(4):550-7
references.pmid: 22239587
references.citation: J Clin Psychiatry. 2011 Apr;72(4):430-40
references.pmid: 21034687
references.citation: Schizophr Res. 2010 Oct;123(1):30-6
references.pmid: 20727717
references.citation: World Psychiatry. 2011 Oct;10(3):165-74
references.pmid: 21991266
references.citation: Schizophr Res. 2012 Jul;138(2-3):206-11
references.pmid: 22520856
references.citation: Psychiatr Q. 2003 Winter;74(4):313-32
references.pmid: 14686457
references.citation: Am J Psychiatry. 2005 Mar;162(3):441-9
references.pmid: 15741458
references.citation: Curr Opin Psychiatry. 2005 Mar;18(2):159-63
references.pmid: 16639169
references.citation: Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
references.pmid: 16343296
references.citation: Br J Psychiatry. 2004 Oct;185:291-7
references.pmid: 15458988
references.citation: J Child Adolesc Psychopharmacol. 2009 Aug;19(4):403-14
references.pmid: 19702492
references.citation: Biol Psychiatry. 2001 Dec 1;50(11):884-97
references.pmid: 11743943
references.citation: Schizophr Res. 2011 Jan;125(1):54-61
references.pmid: 21074974
references.citation: Br J Psychiatry Suppl. 2007 Dec;51:s88-95
references.pmid: 18055944
references.citation: Arch Gen Psychiatry. 2002 Oct;59(10):921-8
references.pmid: 12365879
references.citation: Schizophr Res. 2011 Mar;126(1-3):51-7
references.pmid: 21035313
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1942-51
references.pmid: 17805306
references.citation: J Child Adolesc Psychopharmacol. 2005 Dec;15(6):901-12
references.pmid: 16379510
references.citation: Acta Psychiatr Scand. 2012 Jul;126(1):21-30
references.pmid: 22335365
references.citation: Am J Psychiatry. 2011 Aug;168(8):800-5
references.pmid: 21498462
references.citation: Schizophr Bull. 2013 Jul;39(4):923-32
references.pmid: 22589370
references.citation: Schizophr Res. 2013 Sep;149(1-3):56-62
references.pmid: 23870806
references.citation: Schizophr Bull. 2012 Sep;38(5):1083-91
references.pmid: 21518921
references.citation: Schizophr Bull. 2012 May;38(3):519-30
references.pmid: 20929968
references.citation: J Affect Disord. 2010 Dec;127(1-3):316-20
references.pmid: 20619465
references.citation: Compr Psychiatry. 2007 Sep-Oct;48(5):479-88
references.pmid: 17707258
references.citation: Early Interv Psychiatry. 2012 Aug;6(3):276-82
references.pmid: 22240056
references.citation: Schizophr Res. 2007 Mar;91(1-3):112-6
references.pmid: 17293083
references.citation: J Clin Psychiatry. 2013 Apr;74(4):349-56
references.pmid: 23218022
references.citation: Schizophr Res. 2007 Nov;96(1-3):25-33
references.pmid: 17611080
references.citation: Schizophr Res. 2006 May;84(1):57-66
references.pmid: 16630707
references.citation: Biol Psychiatry. 2013 Jul 15;74(2):106-12
references.pmid: 23312565
references.citation: Psychiatry Res. 2011 Oct 31;194(1):1-6
references.pmid: 21831606